Published by TMR Research Insights
Posted on August 24, 2021
The Asia preimplantation genetic diagnosis market has a highly competitive vendor landscape, observes Transparency Market Research (TMR). The market players are on a quest to increase their profit margins, which has brought them neck and neck in the race for market share. The competition is expected to further intensify over the coming years as the leading players resort to a range of strategies to establish their worth in the minds of the consumers. Furthermore, the market is highly fragmented on account of a large host of small-. Medium-, and large-scale service providers in the market. Perkin Elmer Inc., Thermo Fisher Scientific Inc., Illumina Inc., F. Hoffmann-La Roche, Natera Inc., and Abbott Laboratories are some of the key players operating in the Asian market.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=9989
The estimates outlined by the researchers at Transparency Market Research (TMR) reveal that the market for preimplantation genetic diagnosis in Asia would grow at a CAGR of 6.80% over the period from 2015 to 2023. The market was valued at US$16.0 mn in 2014 and is projected to touch a value of US$28.8 mn by the end of 2023. East Asia registered a high growth rate over the past years with a total opportunity worth US$ 6.0 mn in 2014.
Growing Medical Tourism to be Beneficial for Growth
Vitro-fertilization has emerged as a key reproductive procedure in Asia, which has given a boost to the demand within the regional market for preimplantation genetic diagnosis. Medical tourism has emerged as a key trend across the entire world, and Asia has become the prime destination to travel for globally-reckoned medical experts. This has played a major role in propelling demand within the Asian market for preimplantation genetic diagnosis.
Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=9989
Rising awareness about genetic disorders has persuaded the masses to resort to preimplantation genetic diagnosis, which has enhanced the growth of the regional market. Single gene disorder screening has replaced prenatal diagnostic testing due to the proven advantages of the former. Thereby, the Asian market is reaping commendable benefits from multiple avenues within the medical and healthcare sector.
Economic Advantage of Treatment to Bolster Demand
The healthcare industry in Asia has attracted a large host of patients from across the globe because of dual reasons. Primarily, the skill and proficiency of the medical practitioners in India and China has resulted in a greater success rate of medical treatments. Secondly, the costs of treatments in Asia are relatively lower than the rates in developed regions. It can be safely estimated that the market in Asia would tread along an immensely lucrative growth path over the course of the coming years.
Buy Preimplantation Genetic Diagnosis Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=9989<ype=S
This information is from the new report by TMR, titled “Transformer Oil Market (Test Type – PGD for Aneuploidy Screening, PGD for Chromosomal Aberrations, PGD for Gender Selection, PGD for HLA Typing, PGD for Single Gene Disorder, and PGD for X-linked diseases; End-user – Fertility Clinics, Health Care Facilities (including hospitals, diagnostic centers, and health care facilities), and Academic Institutes and Research Centers) – Global Industry Analysis Size Share Growth Trends and Forecast 2016 – 2024.”
More Trending Reports by Transparency Market Research –
Cerebral Somatic Oximeters Market: https://www.prnewswire.com/news-releases/rapidly-ageing-global-population-to-present-abundant-growth-opportunities-for-the-cerebral-somatic-oximeters-market-rise-in-hypoxic-ischemic-encephalopathy-to-boost-demand-in-the-market-tmr-301260665.html
Cholesterol Lowering Drugs Market: https://www.prnewswire.com/news-releases/researchers-harness-potential-of-bempedoic-acid-to-stir-pipelines-in-cholesterol-lowering-drugs-market-better-outcomes-in-lowering-cardiovascular-risks-key-objective-finds-tmr-301026715.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information, we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Transparency Market Research
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Blog: https://tmrblog.com/
Follow Us: Twitter | LinkedIn
Press Release Source: https://www.transparencymarketresearch.com/pressrelease/asia-preimplantation-genetic-diagnosis-market.htm
The Asia preimplantation genetic diagnosis market has a highly competitive vendor landscape, observes Transparency Market Research (TMR). The market players are on a quest to increase their profit margins, which has brought them neck and neck in the race for market share. The competition is expected to further intensify over the coming years as the leading players resort to a range of strategies to establish their worth in the minds of the consumers. Furthermore, the market is highly fragmented on account of a large host of small-. Medium-, and large-scale service providers in the market. Perkin Elmer Inc., Thermo Fisher Scientific Inc., Illumina Inc., F. Hoffmann-La Roche, Natera Inc., and Abbott Laboratories are some of the key players operating in the Asian market.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=9989
The estimates outlined by the researchers at Transparency Market Research (TMR) reveal that the market for preimplantation genetic diagnosis in Asia would grow at a CAGR of 6.80% over the period from 2015 to 2023. The market was valued at US$16.0 mn in 2014 and is projected to touch a value of US$28.8 mn by the end of 2023. East Asia registered a high growth rate over the past years with a total opportunity worth US$ 6.0 mn in 2014.
Growing Medical Tourism to be Beneficial for Growth
Vitro-fertilization has emerged as a key reproductive procedure in Asia, which has given a boost to the demand within the regional market for preimplantation genetic diagnosis. Medical tourism has emerged as a key trend across the entire world, and Asia has become the prime destination to travel for globally-reckoned medical experts. This has played a major role in propelling demand within the Asian market for preimplantation genetic diagnosis.
Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=9989
Rising awareness about genetic disorders has persuaded the masses to resort to preimplantation genetic diagnosis, which has enhanced the growth of the regional market. Single gene disorder screening has replaced prenatal diagnostic testing due to the proven advantages of the former. Thereby, the Asian market is reaping commendable benefits from multiple avenues within the medical and healthcare sector.
Economic Advantage of Treatment to Bolster Demand
The healthcare industry in Asia has attracted a large host of patients from across the globe because of dual reasons. Primarily, the skill and proficiency of the medical practitioners in India and China has resulted in a greater success rate of medical treatments. Secondly, the costs of treatments in Asia are relatively lower than the rates in developed regions. It can be safely estimated that the market in Asia would tread along an immensely lucrative growth path over the course of the coming years.
Buy Preimplantation Genetic Diagnosis Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=9989<ype=S
This information is from the new report by TMR, titled “Transformer Oil Market (Test Type – PGD for Aneuploidy Screening, PGD for Chromosomal Aberrations, PGD for Gender Selection, PGD for HLA Typing, PGD for Single Gene Disorder, and PGD for X-linked diseases; End-user – Fertility Clinics, Health Care Facilities (including hospitals, diagnostic centers, and health care facilities), and Academic Institutes and Research Centers) – Global Industry Analysis Size Share Growth Trends and Forecast 2016 – 2024.”
More Trending Reports by Transparency Market Research –
Cerebral Somatic Oximeters Market: https://www.prnewswire.com/news-releases/rapidly-ageing-global-population-to-present-abundant-growth-opportunities-for-the-cerebral-somatic-oximeters-market-rise-in-hypoxic-ischemic-encephalopathy-to-boost-demand-in-the-market-tmr-301260665.html
Cholesterol Lowering Drugs Market: https://www.prnewswire.com/news-releases/researchers-harness-potential-of-bempedoic-acid-to-stir-pipelines-in-cholesterol-lowering-drugs-market-better-outcomes-in-lowering-cardiovascular-risks-key-objective-finds-tmr-301026715.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information, we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Transparency Market Research
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Blog: https://tmrblog.com/
Follow Us: Twitter | LinkedIn
Press Release Source: https://www.transparencymarketresearch.com/pressrelease/asia-preimplantation-genetic-diagnosis-market.htm
Explore more articles in the Research Reports category
